Levon A Bostanian

511 total citations
29 papers, 407 citations indexed

About

Levon A Bostanian is a scholar working on Pharmaceutical Science, Pediatrics, Perinatology and Child Health and Molecular Biology. According to data from OpenAlex, Levon A Bostanian has authored 29 papers receiving a total of 407 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pharmaceutical Science, 7 papers in Pediatrics, Perinatology and Child Health and 5 papers in Molecular Biology. Recurrent topics in Levon A Bostanian's work include Advanced Drug Delivery Systems (8 papers), Pharmaceutical studies and practices (7 papers) and Drug Solubulity and Delivery Systems (5 papers). Levon A Bostanian is often cited by papers focused on Advanced Drug Delivery Systems (8 papers), Pharmaceutical studies and practices (7 papers) and Drug Solubulity and Delivery Systems (5 papers). Levon A Bostanian collaborates with scholars based in United States. Levon A Bostanian's co-authors include Tarun K. Mandal, Richard A Graves, Sarala Pamujula, Thomas B. Freeman, Vimal Kishore, Trong Duy Nguyen, Robert C. Blake, Yashoda V Pramar, Venkataraman Srinivasan and Daniel Poole and has published in prestigious journals such as International Journal of Molecular Sciences, International Journal of Pharmaceutics and Biosensors and Bioelectronics.

In The Last Decade

Levon A Bostanian

28 papers receiving 393 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Levon A Bostanian United States 13 161 101 79 75 57 29 407
Dimitris Fatouros Greece 14 220 1.4× 92 0.9× 33 0.4× 54 0.7× 73 1.3× 19 460
Jingwen Weng China 11 177 1.1× 116 1.1× 44 0.6× 63 0.8× 105 1.8× 20 503
Neha Dabholkar India 8 213 1.3× 71 0.7× 34 0.4× 60 0.8× 101 1.8× 8 450
Gladys E. Granero Argentina 10 120 0.7× 46 0.5× 34 0.4× 40 0.5× 66 1.2× 25 402
Ashwini Deshpande India 13 165 1.0× 96 1.0× 57 0.7× 92 1.2× 181 3.2× 40 545
Hany S.M. Ali Egypt 12 428 2.7× 123 1.2× 63 0.8× 146 1.9× 93 1.6× 27 737
Araz Sabzevari Iran 10 239 1.5× 135 1.3× 32 0.4× 63 0.8× 96 1.7× 14 517
Orsolya Jójárt‐Laczkovich Hungary 13 217 1.3× 76 0.8× 69 0.9× 75 1.0× 54 0.9× 35 453
Sunny Shah India 16 322 2.0× 112 1.1× 46 0.6× 103 1.4× 99 1.7× 50 678
Roshan Pradhan South Korea 12 195 1.2× 100 1.0× 26 0.3× 54 0.7× 75 1.3× 20 364

Countries citing papers authored by Levon A Bostanian

Since Specialization
Citations

This map shows the geographic impact of Levon A Bostanian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Levon A Bostanian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Levon A Bostanian more than expected).

Fields of papers citing papers by Levon A Bostanian

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Levon A Bostanian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Levon A Bostanian. The network helps show where Levon A Bostanian may publish in the future.

Co-authorship network of co-authors of Levon A Bostanian

This figure shows the co-authorship network connecting the top 25 collaborators of Levon A Bostanian. A scholar is included among the top collaborators of Levon A Bostanian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Levon A Bostanian. Levon A Bostanian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pramar, Yashoda V, et al.. (2022). Physicochemical and Microbiological Stability of Amitriptyline Hydrochloride Oral Liquid Dosage Forms in PCCA Base, SuspendIt.. PubMed. 26(4). 342–351. 1 indexed citations
2.
Pramar, Yashoda V, et al.. (2021). Physicochemical and Microbiological Stability of Extemporaneously Compounded Hydrocortisone Oral Suspensions in PCCA Base, SuspendIt.. PubMed. 25(5). 431–439. 2 indexed citations
3.
Graves, Richard A, et al.. (2020). Physicochemical Stability of Compounded Amlodipine Besylate Suspensions in PCCA Base, SuspendIt.. PubMed. 23(6). 519–527. 2 indexed citations
4.
Pramar, Yashoda V, et al.. (2019). Stability of Compounded Ursodiol Suspensions in PCCA Base, SuspendIt.. PubMed. 23(1). 70–76. 5 indexed citations
5.
Graves, Richard A, et al.. (2018). Physicochemical Stability of an Oral Suspension of Trimethoprim 20 mg/mL in Combination with Sulfadiazine 200 mg/mL in PCCA Base SuspendIt.. PubMed. 21(5). 430–435. 2 indexed citations
6.
Pramar, Yashoda V, et al.. (2017). Stability of Clindamycin Hydrochloride in PCCA Base SuspendIt.. PubMed. 20(5). 421–425. 2 indexed citations
7.
Graves, Richard A, et al.. (2015). Formulation and evaluation of biodegradable nanoparticles for the oral delivery of fenretinide. European Journal of Pharmaceutical Sciences. 76. 1–9. 19 indexed citations
8.
Graves, Richard A, et al.. (2015). Effect of squalane on mebendazole-loaded Compritol®nanoparticles. Journal of Biomaterials Science Polymer Edition. 26(13). 868–880. 8 indexed citations
9.
Graves, Richard A, et al.. (2015). A second-generation inhaled insulin for diabetes mellitus. American Journal of Health-System Pharmacy. 72(14). 1181–1187. 17 indexed citations
10.
Graves, Richard A, et al.. (2014). An ultra-high performance chromatographic method for the determination of artemisinin. Drug Development and Industrial Pharmacy. 41(5). 819–824. 6 indexed citations
11.
Graves, Richard A, et al.. (2014). Preparation and in vitro evaluation of hydrophilic fenretinide nanoparticles. International Journal of Pharmaceutics. 479(2). 329–337. 17 indexed citations
12.
Graves, Richard A, et al.. (2008). Encapsulation of Indomethacin Using Coaxial Ultrasonic Atomization Followed by Solvent Evaporation. Drug Development and Industrial Pharmacy. 34(4). 419–426. 12 indexed citations
13.
Pamujula, Sarala, et al.. (2008). Preparation of polylactide-co-glycolide and chitosan hybrid microcapsules of amifostine using coaxial ultrasonic atomizer with solvent evaporation. Journal of Pharmacy and Pharmacology. 60(3). 283–289. 16 indexed citations
14.
Graves, Richard A, et al.. (2008). Spray-Dried Chitosan as a Direct Compression Tableting Excipient. Drug Development and Industrial Pharmacy. 35(1). 43–48. 48 indexed citations
15.
Graves, Richard A, et al.. (2003). Effect of different ratios of high and low molecular weight PLGA blend on the characteristics of pentamidine microcapsules. International Journal of Pharmaceutics. 270(1-2). 251–262. 44 indexed citations
16.
Mandal, Tarun K., et al.. (2002). Poly(d,l-Lactide-Co-Glycolide) Encapsulated Poly(Vinyl Alcohol) Hydrogel as a Drug Delivery System. Pharmaceutical Research. 19(11). 1713–1719. 54 indexed citations
17.
Blake, Robert C., et al.. (2002). Near real-time biosensor-based detection of 2,4-dinitrophenol. Biosensors and Bioelectronics. 18(1). 69–72. 17 indexed citations
18.
Mandal, Tarun K., et al.. (2002). Development of Biodegradable Microcapsules as Carrier for Oral Controlled Delivery of Amifostine. Drug Development and Industrial Pharmacy. 28(3). 339–344. 13 indexed citations
19.
Mandal, Tarun K., et al.. (2001). Porous biodegradable microparticles for delivery of pentamidine. European Journal of Pharmaceutics and Biopharmaceutics. 52(1). 91–96. 35 indexed citations
20.
Mandal, Tarun K., Tarun K. Mandal, & Levon A Bostanian. (2000). Effect of Peptide Loading and Surfactant Concentration on the Characteristics of Physically Crosslinked Hydrogel. Pharmaceutical Development and Technology. 5(4). 555–560. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dimitris Fatouros Breakdown of academic impact, for papers by Jingwen Weng Breakdown of academic impact, for papers by Neha Dabholkar Breakdown of academic impact, for papers by Gladys E. Granero Breakdown of academic impact, for papers by Ashwini Deshpande Breakdown of academic impact, for papers by Hany S.M. Ali Breakdown of academic impact, for papers by Araz Sabzevari Breakdown of academic impact, for papers by Orsolya Jójárt‐Laczkovich Breakdown of academic impact, for papers by Sunny Shah Breakdown of academic impact, for papers by Roshan Pradhan
Rankless by CCL
2026